P21 deficiency delays regeneration of skeletal muscular tissue

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Chinzei, Nobuaki ^a   Hayashi, Shinya ^a   Ueha, Takeshi ^a   Fujishiro, Takaaki ^a   Kanzaki, Noriyuki ^a   Hashimoto, Shingo ^a   Sakata, Shuhei ^a   Kihara, Shinsuke ^a   Haneda, Masahiko ^a   Sakai, Yoshitada ^a   Kuroda, Ryosuke ^a   Kurosaka, Masahiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA; MYOD PROTEIN; MYOGENIN; PROTEIN P21; TRANSCRIPTION FACTOR PAX7; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DIFFERENTIATION ANTIGEN; KI 67 ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; MOUSE; MUSCLE INJURY; MUSCLE MASS; MUSCLE REGENERATION; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN FUNCTION; SKELETAL MUSCLE; TISSUE CHARACTERIZATION; ANATOMY AND HISTOLOGY; ANIMAL; CELL MEMBRANE; CYTOLOGY; DEFICIENCY; GENETICS; INJURIES; KNOCKOUT MOUSE; METABOLISM; MUSCLE DEVELOPMENT; PHYSIOLOGY; REGENERATION; WOUND HEALING;

MUS;

ANIMALS; ANTIGENS, DIFFERENTIATION; CELL MEMBRANE; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; KI-67 ANTIGEN; MICE; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; PROLIFERATING CELL NUCLEAR ANTIGEN; REGENERATION; RNA, MESSENGER; WOUND HEALING;

EID: 84929223597     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125765     Document Type: Article

References (40)

1. Ekstrand J, Hagglund M, Walden M. Epidemiology of muscle injuries in professional football (soccer). Am J Sports Med. 2011; 39: 1226-1232. doi: 10.1177/0363546510395879 PMID: 21335353
2. Brooks JH, Fuller CW, Kemp SP, Reddin DB. Incidence, risk, and prevention of hamstring muscle injuries in professional rugby union. Am J Sports Med. 2006; 34: 1297-1306. PMID: 16493170
3. Jarvinen TA, Jarvinen TL, Kaariainen M, Aarimaa V, Vaittinen S, Kalimo H, et al. Muscle injuries: optimising recovery. Best Pract Res Clin Rheumatol. 2007; 21: 317-331. PMID: 17512485
4. Souza J, Gottfried C. Muscle injury: review of experimental models. J Electromyogr Kinesiol. 2013; 23: 1253-1260. doi: 10.1016/j.jelekin.2013.07.009 PMID: 24011855
5. Jarvinen TA, Jarvinen M, Kalimo H. Regeneration of injured skeletal muscle after the injury. Muscles Ligaments Tendons J. 2013; 3: 337-345. PMID: 24596699
6. Markovic G, Fonda B, Nejc S. Does whole-body cryotherapy affect the recovery process after hamstring damaging exercise: a crossover study. Br J Sports Med. 2014; 48: 633.
7. Yokoi Y, Yanagihashi R, Morishita K, Fujiwara T, Abe K. Effects of exposure to normobaric hyperoxia on the recovery of local muscle fatigue in the quadriceps femoris of young people. J Phys Ther Sci. 2014; 26: 455-460. doi: 10.1589/jpts.26.455 PMID: 24707107
8. Imtiyaz S, Veqar Z, Shareef MY. To Compare the Effect of Vibration Therapy and Massage in Prevention of Delayed Onset Muscle Soreness (DOMS). J Clin Diagn Res. 2014; 8: 133-136. doi: 10.7860/JCDR/2014/7082.4029 PMID: 24701504
9. Oe K, Ueha T, Sakai Y, Niikura T, Lee SY, Koh A, et al. The effect of transcutaneous application of carbon dioxide (CO(2)) on skeletal muscle. Biochem Biophys Res Commun. 2011; 407: 148-152. doi: 10.1016/j.bbrc.2011.02.128 PMID: 21371433
10. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 2004; 84: 209-238. PMID: 14715915
11. Kuribayashi K, El-Deiry WS. Regulation of programmed cell death by the p53 pathway. Adv Exp Med Biol. 2008; 615: 201-221. doi: 10.1007/978-1-4020-6554-5-10 PMID: 18441595
12. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005; 65: 3980-3985. PMID: 15899785
13. Bedelbaeva K, Snyder A, Gourevitch D, Clark L, Zhang XM, Leferovich J, et al. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc Natl Acad Sci U S A. 2010; 107: 5845-5850. doi: 10.1073/pnas.1000830107 PMID: 20231440
14. Olive M, Mellad JA, Beltran LE, Ma M, Cimato T, Noguchi AC, et al. p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis inmice. J Clin Invest. 2008; 118: 2050-2061. doi: 10.1172/JCI31244 PMID: 18464929
15. Guo K, Wang J, Andres V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 1995; 15: 3823-3829. PMID: 7791789
16. Andres V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol. 1996; 132: 657-666. PMID: 8647896
17. Guo K, Walsh K. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. Journal of Biological Chemistry. 1997; 272: 791-797. PMID: 8995365
18. Hall-Craggs EC, Seyan HS. Histochemical changes in innervated and denervated skeletal muscle fibers following treatment with bupivacaine (marcain). Exp Neurol. 1975; 46: 345-354. PMID: 234847
19. Ishiura S, Nonaka I, Sugita H. Biochemical aspects of bupivacaine-induced acute muscle degradation. J Cell Sci. 1986; 83: 197-212. PMID: 3543032
20. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; 182: 311-322. PMID: 10653597
21. Baple EL, Chambers H, Cross HE, Fawcett H, Nakazawa Y, Chioza BA, et al. Hypomorphic PCNA mutation underlies a human DNA repair disorder. J Clin Invest. 2014; 124: 3137-3146. doi: 10.1172/JCI74593 PMID: 24911150
22. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 1981; 11: 805-815. PMID: 7308288
23. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005; 4: 281-286. PMID: 16101534
24. Agley CC, Velloso CP, Lazarus NR, Harridge SD. An image analysis method for the precise selection and quantitation of fluorescently labeled cellular constituents: application to the measurement of human muscle cells in culture. J Histochem Cytochem. 2012; 60: 428-438. doi: 10.1369/0022155412442897 PMID: 22511600
25. Dickson G, Azad A, Morris GE, Simon H, Noursadeghi M, Walsh FS. Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes. J Cell Sci. 1992; 103 (Pt 4): 1223-1233. PMID: 1283164
26. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A. 1993; 90: 3710-3714. PMID: 8475120
27. Gawlik KI, Durbeej M. Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle. 2011; 1: 9. doi: 10.1186/2044-5040-1-9 PMID: 21798088
28. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1988; 107: 1589-1598. PMID: 3049626
29. Warren GL, Hulderman T, Mishra D, Gao X, Millecchia L, O'Farrell L, et al. Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J. 2005; 19: 413-415. PMID: 15601671
30. Iwata A, Fuchioka S, Hiraoka K, Masuhara M, Kami K. Characteristics of locomotion, muscle strength, and muscle tissue in regenerating rat skeletal muscles. Muscle Nerve. 2010; 41: 694-701. doi: 10.1002/mus.21567 PMID: 20405501
31. Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol. 1998; 18: 629-643. PMID: 9418909
32. Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell. 2007; 129: 665-679. PMID: 17512402
33. Mavers M, Cuda CM, Misharin AV, Gierut AK, Agrawal H, Weber E, et al. Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis. Arthritis and Rheumatism. 2012; 64: 141-152. doi: 10.1002/art.33311 PMID: 21898359
34. Apponi LH, Corbett AH, Pavlath GK. RNA-binding proteins and gene regulation in myogenesis. Trends Pharmacol Sci. 2011; 32: 652-658. doi: 10.1016/j.tips.2011.06.004 PMID: 21982546
35. Horie M, Enomoto M, Shimoda M, Okawa A, Miyakawa S, Yagishita K. Enhancement of satellite cell differentiation and functional recovery in injured skeletal muscle by hyperbaric oxygen treatment. J Appl Physiol (1985). 2014; 116: 149-155. doi: 10.1152/japplphysiol.00235.2013 PMID: 24336879
36. Chan YS, Li Y, Foster W, Fu FH, Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med. 2005; 33: 43-51. PMID: 15610998
37. Ma JF, Hall DT, Gallouzi IE. The impact of mRNA turnover and translation on age-related muscle loss. Ageing Res Rev. 2012; 11: 432-441. doi: 10.1016/j.arr.2012.05.004 PMID: 22687959
38. Brand-Saberi B. Genetic and epigenetic control of skeletal muscle development. Ann Anat. 2005; 187: 199-207. PMID: 16130819
39. Schiaffino S, Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle. 2011; 1: 4. doi: 10.1186/2044-5040-1-4 PMID: 21798082
40. Figliola R, Maione R. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors. J Cell Physiol. 2004; 200: 468-475. PMID: 15254975